1. Home
  2. UAMY vs AMPH Comparison

UAMY vs AMPH Comparison

Compare UAMY & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$10.47

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$21.09

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAMY
AMPH
Founded
1968
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1997
2005

Fundamental Metrics

Financial Performance
Metric
UAMY
AMPH
Price
$10.47
$21.09
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$7.69
$30.29
AVG Volume (30 Days)
10.0M
406.4K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
66.67
N/A
EPS
N/A
2.03
Revenue
$14,937,962.00
$719,887,000.00
Revenue This Year
$164.09
$8.00
Revenue Next Year
$218.34
$4.42
P/E Ratio
N/A
$9.86
Revenue Growth
71.84
N/A
52 Week Low
$1.21
$19.83
52 Week High
$19.71
$31.26

Technical Indicators

Market Signals
Indicator
UAMY
AMPH
Relative Strength Index (RSI) 64.90 25.89
Support Level $6.57 $20.41
Resistance Level $11.97 $22.90
Average True Range (ATR) 0.82 1.18
MACD 0.21 -0.86
Stochastic Oscillator 96.35 12.39

Price Performance

Historical Comparison
UAMY
AMPH

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: